Bladder cancer is a genitourinary (urinary tract) malignancy. For veterans, it is one of the relatively few cancers recognized as presumptive under multiple VA toxic exposure frameworks, which can make establishing service connection more straightforward when the qualifying service is met.
Bladder cancer is currently presumptive under four separate VA frameworks: burn pits and other fine particulate matter (PACT Act), Agent Orange and other herbicides, ionizing radiation, and Camp Lejeune contaminated water. It is not covered by any asbestos presumption. The eligibility rules differ for each framework, so the qualifying service period and location determine which pathway applies.
Linked Military Exposures
Burn Pits / PACT Act
Bladder cancer is presumptive as a genitourinary cancer under the PACT Act burn pit and fine particulate matter framework. VA added urinary bladder, ureter, and related genitourinary cancers to the presumptive list effective January 2, 2025, a 2024/2025 expansion that went beyond the original 2022 respiratory cancer list. This pathway generally covers qualifying Gulf War service in Southwest Asia on or after August 2, 1990, and post-9/11 service in covered locations on or after September 11, 2001. With a qualifying diagnosis and service, you do not need to prove your service caused the cancer. See Federal Register: Presumptive service connection for bladder, ureter, and related genitourinary cancers.
Agent Orange / Herbicides
Bladder cancer is a presumptive condition for veterans with qualifying herbicide (Agent Orange) exposure. It was added to the Agent Orange presumptive list effective January 1, 2021 under Public Law 116-283. Veterans with qualifying service (for example, Vietnam during the recognized period and other recognized herbicide exposure locations) who are diagnosed with bladder cancer may be presumed service connected. VA has reviewed certain previously denied claims for these added conditions. See VA: Agent Orange exposure.
Ionizing Radiation
Bladder cancer is covered as part of cancer of the urinary tract among the diseases presumptively associated with ionizing radiation exposure under 38 CFR 3.309(d). This pathway requires that the veteran participated in a defined radiation-risk activity (such as certain atmospheric nuclear test participation or occupation of Hiroshima or Nagasaki), not merely general service. See VA: Ionizing radiation exposure.
Camp Lejeune Contaminated Water
Bladder cancer is one of the eight presumptive conditions tied to the contaminated drinking water at Camp Lejeune. Eligibility generally requires at least 30 cumulative days of service at Camp Lejeune or MCAS New River between August 1, 1953 and December 31, 1987, without a dishonorable discharge, plus a qualifying diagnosis. See VA: Camp Lejeune water contamination.
VA Presumptive Status
Bladder cancer is currently presumptive under four VA frameworks: (1) burn pits and fine particulate matter under the PACT Act, as a genitourinary cancer added effective January 2, 2025 for qualifying Gulf War (Southwest Asia, on or after August 2, 1990) and post-9/11 (covered locations, on or after September 11, 2001) service; (2) Agent Orange and other herbicides, added effective January 1, 2021 under Public Law 116-283; (3) ionizing radiation, as part of cancer of the urinary tract under 38 CFR 3.309(d), which requires participation in a defined radiation-risk activity; and (4) Camp Lejeune contaminated water, as one of the eight presumptive conditions (30 or more cumulative days, August 1, 1953 to December 31, 1987).
Bladder cancer is not presumptive based on asbestos exposure; there is no asbestos presumption for it. Even when a presumption does not apply, a veteran may still pursue direct service connection with supporting evidence. Eligibility under each presumptive framework depends on meeting that framework's specific service requirements.
How the VA Rates It
While active: 100 percent during active malignancy and for 6 months after surgery, radiation, chemotherapy, or other treatment ends, then a mandatory re-examination.
After remission (residuals): If no recurrence or metastasis, rated on the residual voiding dysfunction or renal (kidney) dysfunction, whichever is predominant. Voiding dysfunction generally does not exceed 60 percent; renal dysfunction can support higher.
38 CFR reference →Estimate combined pay with the disability calculator, or browse all cancer ratings.
Screening & Early Detection
There is no broadly recommended routine screening test for bladder cancer in people without symptoms or risk factors, so screening decisions are individualized. Common warning signs that warrant prompt medical evaluation include blood in the urine (which may be visible or microscopic), changes in urination, or pelvic pain. Veterans with known toxic exposures or other risk factors may wish to discuss their personal risk and any monitoring with their VA or other health care provider. This information is general and is not a substitute for professional medical advice.
Sources
- https://www.va.gov/resources/the-pact-act-and-your-va-benefits/
- https://www.va.gov/disability/eligibility/hazardous-materials-exposure/agent-orange/
- https://www.va.gov/disability/eligibility/hazardous-materials-exposure/camp-lejeune-water-contamination/
- https://www.va.gov/disability/eligibility/hazardous-materials-exposure/ionizing-radiation/
- https://www.federalregister.gov/documents/2025/01/02/2024-31220/presumptive-service-connection-for-bladder-ureter-and-related-genitourinary-cancers-due-to-exposure
- https://www.ecfr.gov/current/title-38/section-3.309
See all cancers linked to service, the full presumptive conditions list, or learn how to file a claim.
This page is for informational purposes only and is not medical or legal advice. Consult a qualified professional about your health or benefits.